Literature DB >> 15249705

Effects of nitric oxide on aldosterone synthesis and nitric oxide synthase activity in glomerulosa cells from bovine adrenal gland.

José M Sainz1, Cecilia Reche, María A Rábano, Carolina Mondillo, Zoraida J Patrignani, José M Macarulla, Omar P Pignataro, Miguel Trueba.   

Abstract

This study investigated the effects of two NO-releasing agents, diethylenetriamine-NO (deta-NO) and sodium nitroprusside (SNP), on basal, ACTH-, and angiotensin II (AngII)-stimulated aldosterone production in glomerulosa cells from bovine adrenal gland. NO donors inhibited basal and ACTH- or AngII-stimulated aldosterone synthesis in a concentration-dependent manner. Deta-NO and SNP also provoked a concentration-dependent stimulation of cGMP production. However, cGMP was not responsible for the inhibition of aldosterone secretion, because a cGMP analog did not reproduce the inhibitory effect. Moreover, soluble guanylyl cyclase or protein kinase G inhibitors did not revert the inhibitory effect of NO on aldosterone production. NO donors did not modify ACTH-stimulated cAMP production or AngII-stimulated PLC activity stimulation, but inhibited 22[R] hydroxycholesterol- or pregnenolone-stimulated aldosteronogenesis. NO can be synthesized in bovine glomerulosa cells because nitrite production was determined and characterization of NOS activity was also performed. Nitrite accumulation was not modified in the presence of ACTH, AngII, or other factors used to induce iNOS. NOS activity that showed a Michaelis-Menten kinetic was NADPH- and calcium-dependent and was inhibited by two competitive inhibitors, L-NAME and L-NMMA. These results show that NO inhibits aldosterone production in glomerulosa cells acting on P450scc and other P450-dependent steroidogenic enzymes, and these cells display NOS activity suggesting that NO can be produced by constitutive NOS isozymes. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249705     DOI: 10.1385/ENDO:24:1:061

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells.

Authors:  R Natarajan; L Lanting; W Bai; E L Bravo; J Nadler
Journal:  J Steroid Biochem Mol Biol       Date:  1997-04       Impact factor: 4.292

2.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Effects of ACTH and angiotensin II on cytosolic calcium in cultured adrenal glomerulosa cells. Role of cAMP production in the ACTH effect.

Authors:  E Tremblay; M D Payet; N Gallo-Payet
Journal:  Cell Calcium       Date:  1991-11       Impact factor: 6.817

4.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

5.  Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.

Authors:  M Côté; M D Payet; E Rousseau; G Guillon; N Gallo-Payet
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

6.  Nitric oxide decreases estradiol synthesis of rat luteinized ovarian cells: possible role for nitric oxide in functional luteal regression.

Authors:  L M Olson; C M Jones-Burton; A Jablonka-Shariff
Journal:  Endocrinology       Date:  1996-08       Impact factor: 4.736

7.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

8.  Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols.

Authors:  M Marzinzig; A K Nussler; J Stadler; E Marzinzig; W Barthlen; N C Nussler; H G Beger; S M Morris; U B Brückner
Journal:  Nitric Oxide       Date:  1997-04       Impact factor: 4.427

9.  The steroidogenic acute regulatory protein is induced by angiotensin II and K+ in H295R adrenocortical cells.

Authors:  B J Clark; V Pezzi; D M Stocco; W E Rainey
Journal:  Mol Cell Endocrinol       Date:  1995-12-29       Impact factor: 4.102

Review 10.  Nitric oxide in the stress axis.

Authors:  M O López-Figueroa; H E Day; H Akil; S J Watson
Journal:  Histol Histopathol       Date:  1998-10       Impact factor: 2.303

View more
  5 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

2.  Nitric oxide inhibits ACTH-induced cortisol production in near-term, long-term hypoxic ovine fetal adrenocortical cells.

Authors:  Tshepo R Monau; Vladimir E Vargas; Lubo Zhang; Dean A Myers; Charles A Ducsay
Journal:  Reprod Sci       Date:  2010-08-16       Impact factor: 3.060

Review 3.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

Review 4.  Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins.

Authors:  Thomas D Giles; Gary E Sander; Bobby D Nossaman; Philip J Kadowitz
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04       Impact factor: 3.738

5.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.